title: Therapeutic properties of mushrooms in managing adverse effects in the metabolic syndrome.
abstract: Metabolic syndrome (MS) is a modern medical condition characterized by central obesity, hyperglycaemia, hypercholesterolemia and hypertension. The beneficial effects of mushrooms in lowering the symptoms of MS were known from both traditional and conventional medicine. Edible mushrooms, their extracts, polysaccharide fractions and isolated compounds possessed hypoglycaemic, cholesterol and triglyceride lowering ability, hypotensive effects, as well as weight managing activity by influencing satiety. The most active compounds are polysaccharides, called β-glucans, as well as lectines and small compounds such as eritadenin, triterpenes, sterols and phenolic compounds.
authors.affiliation: Department of Pharmacognosy, Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia. ktatjana@pharmacy.bg.ac.rs.
authors.forename: Tatjana
authors.initials: T
authors.lastname: Kundaković
authors.forename: Marina
authors.initials: M
authors.lastname: Kolundžić
mesh_terms: D000363:Agaricales / Q000737:chemistry*; D000364:Agaricus / Q000737:chemistry; D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy; D006973:Hypertension / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000494:pharmacology; D024821:Metabolic Syndrome / Q000150:complications / Q000178:diet therapy* / Q000188:drug therapy*; D009765:Obesity / Q000517:prevention & control
chemical_list: D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents